Russo Ltd. Innovators need innovative communications strategies. We represent many of the public biotechnology companies as well as early stage private startup companies that make Europe a major player in biopharmaceutical research and development. Our effectiveness is based on experience and expertise. We understand the challenges and complexities our clients face. We know the individuals and organisations that shape media, investor and professional opinion across Europe.
New strategies develop.
Most of our staff members are bilingual, fluent in the most widely used European languages and English. The availability of this team synergy, at any given time or place, means that clients have worldwide investor and media relations as well as marketing communications, medical advocacy, patient accrual and product marketing. A company's communications impacts all of its facets, including recruitment of top managers, business partners and financing. We design and implement media programmes that effectively support our clients' positioning strategies as well as marketing and financial objectives. Our strong, long-term relationships with the leading business, scientific and trade journalists in many of Europe's capitals and our targeted approach in reaching them produce substantial coverage in influential publications and place clients as authoritative industry sources.